Drug or technology

blood sampling

3 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 3, 2026 · INTERVENTIONAL STUDY

Longitudinal Profiling of Plasma-Derived Glial Extracellular Vesicles in Alzheimer's Disease

ClinicalTrials.gov

This is a recruiting registry record with no reported results; it describes a planned longitudinal observational study of biomarkers across the Alzheimer's disease continuum.

PreliminaryAlzheimer's Disease Dementia Fondazione Policlinico Universitario Agostino Gemelli IRCCS Mild Cognitive Impairment (MCI) Due to Alzheimer's Disease

Reported

Planned enrollment48

Primary outcome measure 1Longitudinal changes at 24 months

Primary outcome measure 2Disease-stage-specific molecular signatures…

AUG 19, 2026 · OBSERVATIONAL STUDY

Dysfunctional Myelopoiesis and Myeloid-Derived Suppressor Cells in Sepsis

ClinicalTrials.gov

This is an active observational registry record with no reported results; it describes a planned mechanistic study of immune cell populations in sepsis without outcome data or effect estimates.

PreliminaryUniversity of Florida NCT05110937 blood sampling

Reported

Planned enrollment450

Primary outcome measureTotal number of neutrophils and early myelo…

Follow-up duration6 months

AUG 14, 2026 · OBSERVATIONAL STUDY

A Study on How the Immune System Responds to Sepsis and Its Long-term Effects

ClinicalTrials.gov

This is an active observational registry study with no results yet posted; it describes planned enrollment and immunophenotyping outcomes but carries no outcome data, effect estimates, or clinical evidence.

Preliminaryblood sampling Radboud University Medical Center Sepsis

Reported

Planned enrollment400

Primary outcome measure 1Classification of hospitalized sepsis patie…

Primary outcome measure 2Classification of hospitalized sepsis patie…